High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
Authors:
Open Access
- 26 November 2015
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 10 (2) , 310-319
Abstract
Background As treatment for chronic hepatitis C (HCV) virus has evolved to all-oral, interferon-free directly acting antiviral (DAA) therapy, the impact of these improvements on patient adherence has not been described. Methods Medication adherence was measured in 60 HCV, genotype-1, treatment-naïve participants enrolled in a phase 2a clinical trial at the National Institutes of Health and community clinics. Participants received either ledipasvir/sofosbuvir (LDV/SOF) (90 mg/400 mg) (one pill) daily for 12 weeks, LDV/SOF + GS-9451 (80 mg/day) (two pills) daily for 6 weeks, or LDV/SOF + GS-9669 (500 mg twice daily; three pills, two in the morning, one in the evening) for 6 weeks. Adherence was measured using medication event monitoring system (MEMS) caps, pill counts and patient report. Results Overall adherence to DAAs was high. Adherence declined over the course of the 12-week treatment (p = 0.04). While controlled psychiatric disease or symptoms of depression did not influence adherence, recent drug use was a risk factor for non-adherence to 12-week (p = 0.01), but not 6-week regimens. Adherence as measured by MEMS was lower than by patient report. Conclusions Adherence to short courses of DAA therapy with 1–3 pills a day was excellent in an urban population with multiple risk factors for non-adherence.Keywords
Funding Information
- Division of Intramural Research
This publication has 25 references indexed in Scilit:
- Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1New England Journal of Medicine, 2014
- Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patientsVirology Journal, 2013
- Gender and racial disparities in adherence to statin therapy: A meta-analysisAmerican Heart Journal, 2013
- Viral Mutation RatesJournal of Virology, 2010
- Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virusJournal of Medical Virology, 2009
- Sociodemographic Trends in National Ambulatory Care Visits for Hepatitis C Virus InfectionDigestive Diseases and Sciences, 2008
- Adherence to MedicationNew England Journal of Medicine, 2005
- Measuring medication adherence: Are missed doses reported more accurately than perfect adherence?AIDS Care, 2000
- Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence InstrumentsAIDS Care, 2000
- Age and DepressionJournal of Health and Social Behavior, 1992